Not independent
Tenure on this board
2.3 yrs
Also a director at
Solid Biosciences Inc (SLDB)Immatics NV (IMTX)
6 nominees · 2 ballot items.
Two management proposals: (1) a special-resolution to amend PCSC’s Memorandum and Articles of Association to extend the deadline to complete a business combination from June 13, 2026 to June 13, 2027, and (2) an ordinary-resolution to adjourn the shareholder meeting if necessary to permit further solicitation of votes or to address Nasdaq listing issues arising from redemptions.
Amend the Memorandum and Articles of Association to extend PCSC’s Termination Date to June 13, 2027 to provide additional time to consummate an initial business combination; includes related redemption protections for public shareholders.
The Extension Amendment Proposal asks shareholders to approve, by special resolution, an amendment to PCSC’s Memorandum and Articles of Association to extend the deadline for completing an initial business combination from June 13, 2026 to June 13, 2027. Management is seeking shareholder approval to provide the company with additional time to consummate the announced business combination with Freenome or, if that transaction fails, to identify and complete another qualifying transaction. The amendment explicitly preserves public shareholders’ redemption rights upon implementation of the extension and adds protections that require redemption rights in respect of other amendments that would affect public holders’ redemption entitlements. The Board frames the extension as necessary to avoid an involuntary liquidation that would extinguish the company’s operating prospects; absent an extension, PCSC would be required to wind up and redeem public shares. The extension also creates the immediate risk that significant redemptions could materially reduce the funds available in the Trust Account and could lead to non-compliance with Nasdaq continued listing requirements, which management acknowledges. The Sponsor, officers and directors have committed to waive redemption rights on their Founder and Private Placement shares, and the Sponsor has limited indemnification obligations designed to protect the Trust Account up to specified amounts, creating potential conflicts of interest the Board discloses and considered. The Board recommends voting FOR the proposal on the basis that additional time increases the likelihood of completing a value-enhancing business combination and that redemption rights protect public holders who prefer cash; investors should weigh that potential against dilution of the Trust Account via redemptions and Nasdaq delisting risk. Overall, the proposal is a typical SPAC extension request that balances the Board’s desire to consummate a business combination with shareholder redemption protections and disclosure of conflicts and listing risks.
Adjourn the shareholder meeting, by ordinary resolution, to a later date or dates if necessary to permit further solicitation of proxies or if redemptions in connection with the Articles Extension would cause noncompliance with Nasdaq listing requirements.
The Adjournment Proposal requests shareholder approval, by ordinary resolution, to adjourn the Shareholder Meeting to one or more later dates if the votes tabulated at the time of the meeting are insufficient to approve the Articles Extension or if redemptions in connection with the Articles Extension would cause PCSC to fall out of compliance with Nasdaq listing standards. Management is seeking this authorization as a procedural safeguard to allow time for additional proxy solicitation, to address potential shortfalls in votes, and to permit public shareholders to withdraw or reverse redemption requests where the Board deems appropriate to preserve listing status and the possibility of completing a business combination. The Adjournment Proposal is conditional and will only be presented if needed—i.e., if the Extension Amendment Proposal lacks sufficient support or redemptions threaten Nasdaq compliance. Approval would give the Board flexibility to continue seeking votes rather than having the meeting fail and triggering liquidation procedures under the existing Articles. The Board recommends a vote FOR this proposal to avoid a premature termination of efforts to consummate a business combination and to preserve optionality for shareholders who wish to remain invested. The principal risk to shareholders is that an adjournment may prolong uncertainty and allow additional redemptions that further reduce the Trust Account; conversely, adjournment could also preserve the ability to complete a transaction that creates value for remaining shareholders. Given the Sponsor and insiders’ public commitment to vote in favor of both proposals, attaining the required votes will largely depend on public shareholder participation and the extent of redemptions. For governance-minded investors, the adjournment is a tactical, not substantive, proposal that primarily affects the timeline and mechanics of the vote rather than the underlying economic terms of any business combination.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | FARALLON CAPITAL MANAGEMENT LLCActivist | 20.33% | 2,250,000 | $25M |
| 2 | One Fin Capital Management LP | 7.62% | 843,482 | $9M |
| 3 | RA CAPITAL MANAGEMENT, L.P. | 6.78% | 750,000 | $8M |
| 4 | RTW INVESTMENTS, LP | 6.71% | 742,500 | $8M |
| 5 | BIT Capital GmbH | 6.69% | 740,264 | $8M |
| 6 | Holocene Advisors, LP | 5.65% | 625,173 | $7M |
| 7 | Aberdeen Group plc | 5.23% | 578,565 | $6M |
| 8 | 683 Capital Management, LLC | 5.08% | 561,923 | $6M |
| 9 | ADAR1 Capital Management, LLC | 4.51% | 499,581 | $5M |
| 10 | Sculptor Capital LP | 3.84% | 424,700 | $5M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.